tiprankstipranks
Trending News
More News >
Ansell (AU:ANN)
ASX:ANN

Ansell (ANN) AI Stock Analysis

Compare
38 Followers

Top Page

AU:ANN

Ansell

(Sydney:ANN)

Select Model
Select Model
Select Model
Outperform 70 (OpenAI - 5.2)
Rating:70Outperform
Price Target:
AU$37.00
â–²(13.36% Upside)
Ansell's strong earnings call performance and solid financials are the most significant factors driving the score. However, technical indicators suggest potential overbought conditions, and the high P/E ratio indicates possible overvaluation. The decline in free cash flow growth is a concern that tempers the overall positive outlook.
Positive Factors
Revenue Growth
Consistent revenue growth indicates strong demand for Ansell's products, enhancing its market position and supporting future expansion.
KBU Acquisition
The successful integration and outperformance of the KBU acquisition enhance operational efficiency and contribute to higher profitability.
Sustainability Achievements
Commitment to sustainability and safety strengthens Ansell's brand reputation and aligns with global trends towards sustainable practices.
Negative Factors
Tariff Challenges
Increased tariffs could pressure margins and require strategic adjustments, potentially affecting profitability and competitive positioning.
Higher SG&A Costs
Rising SG&A costs can erode profit margins, necessitating efficient cost management to maintain financial health and shareholder returns.
Cash Flow Reduction
Reduced cash flow can limit investment capacity and flexibility, impacting the company's ability to fund growth initiatives and manage debt.

Ansell (ANN) vs. iShares MSCI Australia ETF (EWA)

Ansell Business Overview & Revenue Model

Company DescriptionAnsell Limited designs, develops, and manufactures protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates in two segments, Healthcare and Industrial. The Healthcare segment manufactures and markets solutions comprising surgical gloves, single use and examination gloves, and clean and sterile gloves and garments, as well as consumables used by hospitals, surgical centers, dental practices, veterinary clinics, first responders, laboratories, and life sciences and pharmaceutical companies. The Industrial segment manufactures and markets hand and chemical protective clothing solutions for a range of industrial applications, including automotive, chemical, metal fabrication, machinery and equipment, food, construction, mining, oil and gas, and first responders. The company was formerly known as Pacific Dunlop Limited and changed its name to Ansell Limited in 2002. Ansell Limited was founded in 1893 and is based in Richmond, Australia. P. D. Holdings Pty. Ltd. operates as a current subsidiary of Ansell Limited.
How the Company Makes MoneyAnsell generates revenue through the sale of its diverse range of protective products across its key sectors. The company operates under multiple revenue streams, including the direct sale of medical gloves to hospitals and healthcare providers, industrial gloves to manufacturers and workers in various industries, and specialty products tailored for specific applications. Significant partnerships with healthcare organizations, industrial firms, and distribution networks enhance Ansell's market reach and drive sales. Additionally, the company invests in research and development to innovate and introduce new products, thereby expanding its offerings and capturing more market share, which significantly contributes to its earnings.

Ansell Earnings Call Summary

Earnings Call Date:Aug 24, 2025
(Q4-2025)
|
Next Earnings Date:Feb 16, 2026
Earnings Call Sentiment Positive
The earnings call reflects a strong performance in FY '25 with significant achievements in revenue growth, successful integration of KBU, and improvements in both the industrial and healthcare segments. However, challenges remain with the impact of U.S. tariffs and increased SG&A costs. The company is optimistic about navigating these challenges with strategic pricing and supply chain adjustments.
Q4-2025 Updates
Positive Updates
Successful FY '25 Performance
EPS reached $1.26, at the upper end of guidance. Organic growth was 8%, translating to a 10% EBIT growth, with adjusted EPS growth approaching 20%. Shareholders were rewarded with a 30% dividend increase.
Industrial Segment Record Results
Record sales, record EBIT margin, and record profitability with organic growth approaching 6% and 10% EBIT growth.
Healthcare Segment Recovery
Healthcare showed strong growth with almost 10% organic growth and improved EBIT margins after overcoming destocking effects.
KBU Acquisition Outperformance
KBU business performance was ahead of the business case, integration completed, synergies target increased from $10 million to $15 million.
Sustainability Achievements
Reduction in injuries by 16% and recognition for sustainability efforts with net zero targets including Scope 3 emissions validated by the science-based targets initiative.
Negative Updates
Tariff Challenges
Significant tariff increases in the U.S., with efforts needed to offset these costs through pricing strategies and supply chain adjustments.
Higher SG&A Costs
SG&A increased by 12.2% on an organic basis, driven by higher incentive accruals and annual merit increases.
Cash Flow Reduction
Net receipts and operating cash flow were lower despite higher sales and earnings, mainly due to inventory build-up and working capital changes.
Company Guidance
During the Ansell Limited FY '25 Full Year Results Briefing, CEO Neil Salmon reported strong financial performance, highlighting an EPS of $1.26, reaching the upper end of their guidance range. The company achieved 8% organic growth, leading to a 10% EBIT growth and a 20% increase in adjusted EPS. Shareholders were rewarded with a 30% dividend increase. For FY '26, Ansell anticipates an EPS guidance range of $1.33 to $1.45, supported by continued sales growth and productivity improvements. The integration of the KBU business exceeded expectations, contributing to the financial results and prompting an increase in synergy targets from $10 million to $15 million. The company also announced a $200 million share buyback program and remains focused on mitigating higher tariffs through pricing strategies and its diverse manufacturing network.

Ansell Financial Statement Overview

Summary
Ansell demonstrates solid financial performance with strong revenue growth and stable margins. The balance sheet is healthy with moderate leverage and a strong equity base. However, the decline in free cash flow growth is a concern that needs addressing.
Income Statement
75
Positive
Ansell's income statement shows a solid revenue growth rate of 8.05% in the latest year, reversing the previous year's decline. The gross profit margin improved to 41.18%, indicating better cost management. However, the net profit margin is relatively low at 5.07%, suggesting room for improvement in profitability. The EBIT and EBITDA margins are moderate, reflecting stable operational efficiency.
Balance Sheet
70
Positive
The balance sheet reflects a stable financial position with a debt-to-equity ratio of 0.41, indicating moderate leverage. The return on equity is 5.17%, which is modest and suggests potential for better utilization of equity. The equity ratio stands at 59.09%, highlighting a strong equity base relative to total assets.
Cash Flow
65
Positive
Cash flow analysis reveals a decline in free cash flow growth by 22.69%, which is a concern. The operating cash flow to net income ratio is 2.36, indicating strong cash generation relative to net income. However, the free cash flow to net income ratio of 1.67 suggests that free cash flow is not as robust as it could be.
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue2.04B2.00B1.62B1.63B1.85B2.04B
Gross Profit838.20M825.00M624.80M604.22M625.19M807.21M
EBITDA284.66M260.20M202.30M275.20M291.90M385.64M
Net Income103.30M101.60M76.50M148.30M158.70M246.70M
Balance Sheet
Total Assets3.32B3.32B3.24B2.52B2.51B2.74B
Cash, Cash Equivalents and Short-Term Investments238.30M238.30M912.30M159.03M206.18M240.21M
Total Debt805.60M805.60M857.20M493.15M485.74M515.53M
Total Liabilities1.34B1.34B1.33B913.07M949.48M1.17B
Stockholders Equity1.96B1.96B1.89B1.60B1.54B1.55B
Cash Flow
Free Cash Flow150.14M170.00M208.60M95.37M127.71M72.17M
Operating Cash Flow219.46M239.30M272.30M161.72M191.71M155.40M
Investing Cash Flow-703.52M-703.30M-63.40M-74.54M-67.51M-85.25M
Financing Cash Flow-196.16M-216.00M540.80M-130.82M-148.76M-250.72M

Ansell Technical Analysis

Technical Analysis Sentiment
Negative
Last Price32.64
Price Trends
50DMA
35.28
Negative
100DMA
34.64
Negative
200DMA
32.73
Positive
Market Momentum
MACD
-0.48
Positive
RSI
35.24
Neutral
STOCH
32.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ANN, the sentiment is Negative. The current price of 32.64 is below the 20-day moving average (MA) of 34.17, below the 50-day MA of 35.28, and below the 200-day MA of 32.73, indicating a neutral trend. The MACD of -0.48 indicates Positive momentum. The RSI at 35.24 is Neutral, neither overbought nor oversold. The STOCH value of 32.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for AU:ANN.

Ansell Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
AU$53.75B24.2426.73%0.95%11.99%32.89%
70
Outperform
$4.77B30.865.27%2.19%25.19%18.82%
56
Neutral
AU$2.02B41.11―2.30%14.61%―
54
Neutral
AU$8.28B1,217.570.38%2.25%6.82%-99.27%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
47
Neutral
AU$99.15M-21.67-4.28%―7.38%82.39%
46
Neutral
AU$1.23B-15.92-54.37%――-29.93%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:ANN
Ansell
33.38
-1.22
-3.52%
AU:RHC
Ramsay Health Care
36.20
3.25
9.85%
AU:CU6
Clarity Pharmaceuticals Ltd.
3.20
-0.48
-13.04%
AU:TRJ
Trajan Group Holdings Ltd
0.64
-0.29
-30.98%
AU:REG
Regis Healthcare Ltd.
6.61
0.22
3.44%
AU:RMD
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
36.40
-3.42
-8.59%

Ansell Corporate Events

Ansell Appoints Former Electrolux Chief Jonas Samuelson to Board
Jan 12, 2026

Ansell Limited has appointed Jonas Samuelson as an independent non-executive director, effective 1 March 2026, and invited him to join its Audit & Compliance Committee. Samuelson, the former President and CEO of Electrolux Group, brings more than three decades of international experience in finance, operations, and general management across major industrial and consumer goods companies, as well as current board roles at Volvo Car and Perrigo. The Ansell board expects his background in global manufacturing, operational transformation, and financial governance to strengthen oversight of complex international operations and support the company’s long-term strategic direction and performance.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$36.50 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Sets Date for FY26 Half-Year Results Amid CEO Transition
Jan 11, 2026

Ansell has announced it will release its half-year financial results for the period ended 31 December 2025 on 16 February 2026, accompanied by a webcast for investors and analysts. The presentation will feature both retiring CEO and Managing Director Neil Salmon and incoming CEO and Managing Director Nathalie Ahlström, alongside CFO Brian Montgomery, highlighting a leadership transition coinciding with the results update and signaling continuity in strategic communication with the market and other stakeholders.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$36.50 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Names Nathalie Ahlström as New CEO as Neil Salmon Retires
Jan 7, 2026

Ansell has announced that Managing Director and Chief Executive Officer Neil Salmon will retire after 13 years with the company, with former Fiskars Group CEO and President Nathalie Ahlström appointed as his successor. Ahlström will join on 26 January 2026 to begin a transition period and formally take over as CEO and Managing Director on 16 February 2026 from Ansell’s Brussels hub, while Salmon will remain as a special adviser to the Board and incoming CEO until 30 June 2026 to ensure continuity for employees, customers and shareholders. The Board highlighted Salmon’s role in driving strong organic growth, productivity improvements, and execution of Ansell’s sustainability strategy, including the successful integration of the Kimberly-Clark PPE business, and expressed confidence that Ahlström’s international leadership experience and focus on innovation and operational excellence will support the company’s next phase of growth and further strengthen its global market position.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$36.50 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Cancels 381,765 Shares Under On-Market Buy-Back
Dec 23, 2025

Ansell Limited has cancelled 381,765 ordinary fully paid shares as part of an on-market buy-back, effective 23 December 2025. The reduction in issued capital reflects the company’s ongoing capital management activities, which may enhance earnings per share and signal confidence in its financial position, with implications for existing shareholders through a more concentrated equity base.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$36.50 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Updates On-Market Buy-Back Progress
Dec 18, 2025

Ansell Limited has announced a daily update in its on-market buy-back program, highlighting a total of 257,699 securities bought back prior to the previous day and an additional 29,022 securities repurchased on December 17, 2025. This ongoing buy-back initiative underscores Ansell’s commitment to capital management and enhancing shareholder value, potentially solidifying its stance in the financial market and benefiting stakeholders through improved stock performance.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$36.50 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Updates on Buy-Back Program
Dec 16, 2025

Ansell Limited has announced an update regarding its ongoing on-market buy-back program, where the company repurchased 21,927 ordinary fully paid securities on the previous day, adding to a total of 235,772 securities bought back before that day. This buy-back initiative is part of Ansell’s strategy to manage its capital structure and potentially enhance shareholder value.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$36.50 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Updates on Buy-Back Program
Dec 15, 2025

Ansell Limited has announced an update on its ongoing buy-back program, detailing the acquisition of 19,170 ordinary fully paid securities on the previous day, bringing the total number of securities bought back to 216,602. This buy-back initiative is part of Ansell’s strategy to optimize its capital structure and enhance shareholder value, reflecting the company’s commitment to maintaining a strong financial position and returning capital to its investors.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$36.50 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Updates on Buy-Back Program
Dec 14, 2025

Ansell Limited has announced an update regarding its ongoing buy-back program, with a total of 19,102 ordinary fully paid securities bought back on the previous day, adding to the cumulative total of 197,500 securities repurchased prior. This buy-back initiative reflects Ansell’s strategic efforts to manage its capital structure and potentially enhance shareholder value, indicating a positive outlook for stakeholders and reinforcing its market position.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$36.50 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Updates on Share Buy-Back Progress
Dec 9, 2025

Ansell Limited has announced an update on its ongoing share buy-back program, detailing the acquisition of 25,501 ordinary fully paid shares on the previous day, adding to a total of 149,087 shares bought back before that day. This buy-back initiative is part of Ansell’s strategy to manage its capital structure and potentially enhance shareholder value, reflecting the company’s commitment to returning capital to its investors.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$36.50 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Updates on Ongoing Share Buy-Back Program
Dec 7, 2025

Ansell Limited has announced an update regarding its ongoing on-market buy-back program, with a daily notification indicating the purchase of 21,982 ordinary fully paid securities on the previous day. This buy-back initiative is part of Ansell’s strategy to manage its capital structure and potentially enhance shareholder value.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$36.50 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Unveils December 2025 Investor Presentation
Dec 3, 2025

Ansell Limited has released an investor presentation for December 2025, highlighting its ongoing commitment to safety solutions and innovation in personal protection equipment. This announcement underscores Ansell’s strategic focus on enhancing its market position and operational impact, aiming to lead the industry towards a safer future while promoting sustainable practices.

The most recent analyst rating on (AU:ANN) stock is a Buy with a A$36.00 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Updates on Buy-Back Program Amid ASX Form Transition
Dec 2, 2025

Ansell Limited has announced an update regarding its ongoing buy-back program, confirming the purchase of 1,774,732 securities before transitioning to a new electronic form due to an interruption in ASX online form processing. This buy-back initiative reflects Ansell’s strategic focus on optimizing its capital structure and enhancing shareholder value, potentially impacting its market positioning and investor relations.

The most recent analyst rating on (AU:ANN) stock is a Buy with a A$36.00 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Announces On-Market Share Buy-Back
Dec 2, 2025

Ansell Limited has announced a new on-market buy-back of its ordinary fully paid shares, as per its recent notification to the ASX. This strategic move is likely aimed at optimizing the company’s capital structure and potentially enhancing shareholder value, reflecting confidence in its financial stability and future growth prospects.

The most recent analyst rating on (AU:ANN) stock is a Buy with a A$36.00 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Initiates On-Market Share Buy-Back Program
Dec 2, 2025

Ansell Limited has announced a daily on-market buy-back of its ordinary fully paid securities, with a maximum of 14,594,488 shares to be repurchased. This move is part of Ansell’s strategy to optimize its capital structure and return value to shareholders, potentially enhancing its market position by demonstrating financial strength and confidence in its future prospects.

The most recent analyst rating on (AU:ANN) stock is a Buy with a A$36.00 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Updates on Market Buy-Back Program
Nov 27, 2025

Ansell Limited announced an update to its ongoing on-market buy-back program, with a total of 1,693,197 securities bought back before the previous day and an additional 38,601 securities purchased on the previous day. This buy-back initiative reflects Ansell’s strategy to manage its capital structure and potentially enhance shareholder value.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$37.20 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Updates on Share Buy-Back Program
Nov 26, 2025

Ansell Limited has announced an update regarding its ongoing share buy-back program, with the latest figures indicating a total of 1,655,750 securities bought back prior to the previous day and an additional 37,447 securities bought back on the previous day. This buy-back initiative is part of Ansell’s strategy to manage its capital structure and potentially enhance shareholder value, reflecting the company’s commitment to optimizing its financial operations.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$37.20 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Updates on Share Buy-Back Progress
Nov 24, 2025

Ansell Limited has announced an update on its ongoing share buy-back program, with a daily buy-back notification indicating that 40,565 ordinary fully paid securities were bought back on the previous day, adding to a total of 1,587,226 securities bought back before that day. This buy-back initiative is part of Ansell’s strategy to manage its capital structure and potentially enhance shareholder value.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$37.20 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Updates on Ongoing Share Buy-Back Program
Nov 23, 2025

Ansell Limited has announced an update regarding its ongoing on-market buy-back of ordinary fully paid securities, with a total of 33,957 securities bought back on the previous day, bringing the total to 1,553,269 securities. This buy-back initiative is part of Ansell’s strategy to optimize its capital structure and potentially enhance shareholder value, reflecting the company’s commitment to maintaining a strong market position and delivering value to its stakeholders.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$37.20 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Updates on Buy-Back Program
Nov 20, 2025

Ansell Limited has announced an update regarding its ongoing on-market buy-back program, where it repurchased a total of 34,055 ordinary fully paid securities on the previous day, adding to the cumulative total of 1,519,214 securities bought back. This buy-back initiative is part of Ansell’s strategy to optimize its capital structure and potentially enhance shareholder value.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$37.20 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Updates on Ongoing Share Buy-Back Program
Nov 19, 2025

Ansell Limited has announced an update regarding its ongoing on-market buy-back program, revealing that a total of 33,255 ordinary fully paid securities were bought back on the previous day, adding to the cumulative total of 1,485,959 securities repurchased. This buy-back initiative is part of Ansell’s strategic efforts to manage its capital structure and enhance shareholder value, reflecting the company’s commitment to optimizing its financial operations.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$37.20 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Issues Performance Share Rights to Employees
Nov 13, 2025

Ansell Limited announced the issuance of 135,406 performance share rights under an employee incentive scheme. These securities are unquoted and subject to transfer restrictions, reflecting the company’s ongoing efforts to incentivize and retain talent, which may strengthen its competitive position in the industry.

The most recent analyst rating on (AU:ANN) stock is a Hold with a A$37.20 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Ansell Limited Announces Successful 2025 AGM Results
Oct 29, 2025

Ansell Limited announced the results of its 2025 Annual General Meeting, where all resolutions were carried with significant majority votes. The meeting included the re-election of directors and approval of the remuneration report, reflecting strong shareholder support and potentially reinforcing Ansell’s strategic direction and governance framework.

The most recent analyst rating on (AU:ANN) stock is a Buy with a A$36.00 price target. To see the full list of analyst forecasts on Ansell stock, see the AU:ANN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 28, 2025